Results 221 to 230 of about 2,380,315 (334)

Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
ABSTRACT Aims Anaemia is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and associated with poor clinical outcomes. While renin–angiotensin system blockers reduce haemoglobin, little is known about the effect of mineralocorticoid receptor antagonists on haemoglobin and in patients with anaemia.
Misato Chimura, Mingming Yang, Alasdair D. Henderson, Pardeep S. Jhund, Kieran F. Docherty, Brian L. Claggett, Akshay S. Desai, Gerasimos Filippatos, Grzegorz Gajos, Katharina Mueller, Andrea Glasauer, Katja Rohwedder, Prabhakar Viswanathan, Carolyn S.P. Lam, Naoki Sato, Michele Senni, Adriaan A. Voors, Faiez Zannad, Mehmet B. Yilmaz, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V. McMurray, on behalf of the FINEARTS‐HF Committees and Investigators   +23 more
wiley   +1 more source

HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease. [PDF]

Biomedicines
Kouroumalis E, Tsomidis I, Voumvouraki A.   +2 more
europepmc   +1 more source

Baseline serum ferritin predicts myocardial iron uptake following intravenous iron therapy – a hypothesis‐generating study

European Journal of Heart Failure, EarlyView.
Abstract Aims Many patients with heart failure (HF) are iron‐deficient. Intravenous (IV) iron therapy improves symptoms and reduces hospitalizations for HF. Several mechanisms have been proposed, including myocardial iron repletion. However, it is unknown if serum iron markers predict the extent of this repletion.
Julio Nunez, Anna Mollar, Mayra Vera‐Aviles, Syeeda Kabir, Akshay Shah, Paolo Polzella, Michael Desborough, Ingrid Cardells, Gema Miñana, Irene del Canto, Vanessa Ferreira, Stefan Piechnik, Alicia Maceira, Samira Lakhal‐Littleton   +13 more
wiley   +1 more source

Iron Status in Sport Horses: Is It Important for Equine Athletes? [PDF]

Int J Mol Sci
Kiełbik P, Witkowska-Piłaszewicz O.
europepmc   +1 more source

Iron deficiency in heart failure: Epidemiology, diagnostic criteria and treatment modalities

ESC Heart Failure, Volume 12, Issue 2, Page 723-726, April 2025.
Stephan von Haehling
wiley   +1 more source

Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR‐HF2 DZHK05 trial): Sex‐specific outcomes

European Journal of Heart Failure, EarlyView.
Abstract Aims Intravenous iron has emerged as a guideline‐recommended therapy in patients with heart failure and iron deficiency, but the potential sex‐related differences in efficacy are unknown. We aimed to assess sex‐specific outcomes in the Intravenous Iron in Patients with Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
Mahir Karakas, Tim Friede, Javed Butler, Khawaja M. Talha, Marius Placzek, Thomas Asendorf, Monika Diek, Anna Nosko, Adriane Stas, Stefan Kluge, Dominik Jarczak, Geraldine DeHeer, Meike Rybczynski, Antoni Bayes‐Genis, Michael Böhm, Andrew J.S. Coats, Frank Edelmann, Gerasimos Filippatos, Gerd Hasenfuß, Wilhelm Haverkamp, Mitja Lainscak, Ulf Landmesser, Iain C. Macdougall, Bela Merkely, Burkert M. Pieske, Fausto J Pinto, Tienush Rassaf, Jennifer K. Visser‐Rogers, Giuseppe Rosano, Maurizio Volterrani, Stephan von Haehling, Markus S. Anker, Wolfram Doehner, Hüseyin Ince, Friedrich Koehler, Gianluigi Savarese, Muhammad Shahzeb Khan, Ursula Rauch Kröhnert, Tommaso Gori, Teresa Trenkwalder, Ibrahim Akin, Christina Paitazoglou, Iwona Kobielusz‐Gembala, Luca Kuthi, Norbert Frey, Manuela Licka, Stefan Kääb, Karl‐Ludwig Laugwitz, Piotr Ponikowski, Stefan D. Anker   +49 more
wiley   +1 more source

New Transferrin Receptor-Targeting Conjugate Effectively Delivers DNA to Mouse Brain. [PDF]

Angew Chem Int Ed Engl
Song MS, Bustos AH, Bastue L, Mikutavicius J, Swiderski P, Clemens KJ, Habib N, Rossi J, Astakhova K.   +8 more
europepmc   +1 more source

Immune dysregulation as a key driver of peripartum cardiomyopathy – an exploratory advanced imaging and biomarker study

European Journal of Heart Failure, EarlyView.
Physiological postpartum remodelling and the pathological processes involved in peripartum cardiomyopathy (PPCM). 18FDG‐PET‐CT, 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography; CCL3, chemokine (C‐C motif) ligand 3; CMR, cardiovascular magnetic resonance; CRP, C‐reactive protein; CSF‐1, colony‐stimulating factor 1; CXCL10 ...
Julian Hoevelmann, Charle Viljoen, Tessa Kotze, Carlos Libhaber, Stephen Jermy, Morné Kahts, Fareda Jakoet‐Bassier, Petronella Samuels, Olivia Briton, Lynette Cilliers, Denise Hilfiker‐Kleiner, Peter van der Meer, Michael Böhm, Ntobeko A.B. Ntusi, Karen Sliwa   +14 more
wiley   +1 more source

TTN‐related dilated cardiomyopathy in a patient with positive unknown familiarity for heart failure and bicuspid aortic valve

ESC Heart Failure, EarlyView.
Simone Sarzilla, Elia Rigamonti, Laura Anna Leo, Francesca Romana Scopigni, Giorgio Moschovitis   +4 more
wiley   +1 more source

Transferrin receptor 1 deficiency in smooth muscle cells attenuates vascular remodeling in hypertensive mice. [PDF]

Hypertens Res
Naito Y, Sawada H, Horimatsu T, Ohmuraya M, Asakura M, Ishihara M.   +5 more
europepmc   +1 more source